Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP
Authors
Keywords
-
Journal
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 36, Issue 1, Pages 241-252
Publisher
SAGE Publications
Online
2015-04-29
DOI
10.1038/jcbfm.2015.79
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebral Circulation
- (2015) Edith Hamel JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
- (2015) Axel Montagne et al. NEURON
- Treatment of vascular risk factors in patients with a diagnosis of Alzheimer’s disease: a systematic review
- (2014) Raffaella Valenti et al. BMC Medicine
- Early Adult to Midlife Cardiovascular Risk Factors and Cognitive Function
- (2014) Kristine Yaffe et al. CIRCULATION
- Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease
- (2014) E. McDade et al. NEUROLOGY
- Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease
- (2013) Anna Csiszar et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Circulating Endothelin-1 Alters Critical Mechanisms Regulating Cerebral Microcirculation
- (2013) Giuseppe Faraco et al. HYPERTENSION
- Hypertension
- (2013) Giuseppe Faraco et al. HYPERTENSION
- Where hypertension happens
- (2013) Timothy L. Reudelhuber JOURNAL OF CLINICAL INVESTIGATION
- The Pathobiology of Vascular Dementia
- (2013) Costantino Iadecola NEURON
- New Insights into the Dementia Epidemic
- (2013) Eric B. Larson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate immunity receptor CD36 promotes cerebral amyloid angiopathy
- (2013) L. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrovascular Effects of Apolipoprotein E
- (2013) Berislav V. Zlokovic JAMA Neurology
- Risk Factors for β-Amyloid Deposition in Healthy Aging
- (2013) Karen M. Rodrigue et al. JAMA Neurology
- Alzheimer Mechanisms and Therapeutic Strategies
- (2012) Yadong Huang et al. CELL
- Small-molecule inducers of Aβ-42 peptide production share a common mechanism of action
- (2012) Karima Bettayeb et al. FASEB JOURNAL
- Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature
- (2012) Daniela Carnevale et al. HYPERTENSION
- Central Cardiovascular Circuits Contribute to the Neurovascular Dysfunction in Angiotensin II Hypertension
- (2012) C. Capone et al. JOURNAL OF NEUROSCIENCE
- Brain and Circulating Levels of Aβ1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain
- (2012) Laibaik Park et al. STROKE
- Angiotensinergic Signaling in the Brain Mediates Metabolic Effects of Deoxycorticosterone (DOCA)-Salt in C57 Mice
- (2011) Justin L. Grobe et al. HYPERTENSION
- Under pressure: the search for the essential mechanisms of hypertension
- (2011) Thomas M Coffman NATURE MEDICINE
- Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-
- (2011) L. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular Contributions to Cognitive Impairment and Dementia
- (2011) Philip B. Gorelick et al. STROKE
- The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension
- (2010) Carmen Capone et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
- (2010) Inna Kuperstein et al. EMBO JOURNAL
- The secretases: enzymes with therapeutic potential in Alzheimer disease
- (2010) Bart De Strooper et al. Nature Reviews Neurology
- Treatment of vascular risk factors is associated with slower decline in Alzheimer disease
- (2009) Y. Deschaintre et al. NEUROLOGY
- Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
- (2009) L. B. Hoffman et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started